CG Oncology, Inc. CGON
Set alert
65.25 USD +3.29 +5.31%
As of Nov 3, 2:37 PM ET
62.35 Day range 65.79
35.80 52-week range 80.97
- YTD
- +57.15%
- 1 year
- +55.72%
- Open
- 62.52
- Prev close
- 61.96
- Mkt cap
- 5.78B
- Vol
- 285.59K
- Avg vol
- 883.07K
- EPS
- -2.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 62.35
- High
- 65.79
- Forward P/E
- -20.51
- Beta
- 0.35
- Short ratio
- 8.13
- Inst. own
- 113.43%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2026
- 50-d avg
- 69.43
- 200-d avg
- 65.90
- 1y target
- 91.08
3M chart
Events in this range
- Aug 6, 2026Earnings: -0.9; estimate -0.66415; surprise -35.51%
- Aug 7, 2026Rating: Truist Securities · Buy → Buy
- Aug 7, 2026Rating: Piper Sandler · Overweight → Overweight
- Aug 7, 2026Rating: RBC Capital · Outperform → Outperform
Signals (18)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 2026 | 5 hours ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
Held by funds
151 US ETFs and mutual funds hold CGON · largest positions
Ownership
Held by insiders 0.23%
Held by institutions 113.43%
Float held by institutions 113.69%
Institutions 344
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RTW Investments LP | 9.61% | 8,514,590 | 527.56M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 7.46% | 6,616,899 | 409.98M | Jun 29, 2026 |
| Decheng Capital LLC | 7.19% | 6,371,669 | 394.79M | Jun 29, 2026 |
| Blackrock Inc. | 7.06% | 6,256,288 | 387.64M | Jun 29, 2026 |
| Wellington Management Group, LLP | 6.01% | 5,324,751 | 329.92M | Jun 29, 2026 |
| FMR, LLC | 4.69% | 4,161,493 | 257.85M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 3.23% | 2,860,428 | 177.23M | Jul 30, 2026 |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 2.90% | 2,574,868 | 159.54M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.69% | 2,383,134 | 147.66M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.16% | 1,911,075 | 118.41M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.94% | 1,720,068 | 106.58M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.74% | 1,541,674 | 95.52M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| KUAN ARTHUR | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 11, 2026 | 198,916 |
| LIU BRIAN GUAN-CHYUN M.D. | Director | Purchase | Jun 24, 2026 | 0 |
| MULAY JAMES J. | Director | Conversion of Exercise of derivative security | Jul 9, 2026 | 0 |
| POST LEONARD E | Director | Conversion of Exercise of derivative security | Oct 14, 2026 | 0 |
| SONG HONG FANG | Director | Sale | Sep 2, 2025 | 0 |